The FDA has approved Furoscix ReadyFlow, an 80 mg/mL subcutaneous furosemide autoinjector delivering IV-equivalent diuresis in under 10 seconds for adult edema in heart failure or CKD.
The Furoscix ReadyFlow auto-injector [Image courtesy of MannKind] MannKind (Nasdaq:MNKD) announced today that it secured $50 million in a private placement and earned a new regulatory nod. In addition ...
The Enable Injections enFuse platform helped Sanofi win FDA clearance for its anticancer treatment administered with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results